Bosentan 6.25-mg/mL Oral Suspension
Download in electronic PDF format for $65
Abstract: A formulation for preparing Bosentan 6.25-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
Loyd V. Allen, Jr., PhD, RPh, formulation, hazardous medication, pulmonary arterial hypertension, bosentan, exercise capacity
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 505
|
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Wung Deanna
|
Jan/Feb 2013
Pg. 24-27
|
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Davidson Gigi S
|
Nov/Dec 2006
Pg. 405-408
|
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
|
Jan/Feb 2010
Pg. 40-45
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009
Pg. 56-62
|
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R, Fox Samantha, Mixon William, Vail Jane
|
Jan/Feb 2012
Pg. 34-41
|
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 492
|
